Literature DB >> 35531111

Progress on deep learning in digital pathology of breast cancer: a narrative review.

Jingjin Zhu1, Mei Liu2, Xiru Li3.   

Abstract

Background and Objective: Pathology is the gold standard criteria for breast cancer diagnosis and has important guiding value in formulating the clinical treatment plan and predicting the prognosis. However, traditional microscopic examinations of tissue sections are time consuming and labor intensive, with unavoidable subjective variations. Deep learning (DL) can evaluate and extract the most important information from images with less need for human instruction, providing a promising approach to assist in the pathological diagnosis of breast cancer. To provide an informative and up-to-date summary on the topic of DL-based diagnostic systems for breast cancer pathology image analysis and discuss the advantages and challenges to the routine clinical application of digital pathology.
Methods: A PubMed search with keywords ("breast neoplasm" or "breast cancer") and ("pathology" or "histopathology") and ("artificial intelligence" or "deep learning") was conducted. Relevant publications in English published from January 2000 to October 2021 were screened manually for their title, abstract, and even full text to determine their true relevance. References from the searched articles and other supplementary articles were also studied. Key Content and Findings: DL-based computerized image analysis has obtained impressive achievements in breast cancer pathology diagnosis, classification, grading, staging, and prognostic prediction, providing powerful methods for faster, more reproducible, and more precise diagnoses. However, all artificial intelligence (AI)-assisted pathology diagnostic models are still in the experimental stage. Improving their economic efficiency and clinical adaptability are still required to be developed as the focus of further researches. Conclusions: Having searched PubMed and other databases and summarized the application of DL-based AI models in breast cancer pathology, we conclude that DL is undoubtedly a promising tool for assisting pathologists in routines, but further studies are needed to realize the digitization and automation of clinical pathology. 2022 Gland Surgery. All rights reserved.

Entities:  

Keywords:  Breast cancer; artificial intelligence (AI); deep learning (DL); digital pathology

Year:  2022        PMID: 35531111      PMCID: PMC9068546          DOI: 10.21037/gs-22-11

Source DB:  PubMed          Journal:  Gland Surg        ISSN: 2227-684X


  135 in total

1.  Critical evaluation of frozen section margins in head and neck cancer resections.

Authors:  Candice Black; Jonathan Marotti; Elena Zarovnaya; Joseph Paydarfar
Journal:  Cancer       Date:  2006-12-15       Impact factor: 6.860

2.  Detection and classification of cancer in whole slide breast histopathology images using deep convolutional networks.

Authors:  Baris Gecer; Selim Aksoy; Ezgi Mercan; Linda G Shapiro; Donald L Weaver; Joann G Elmore
Journal:  Pattern Recognit       Date:  2018-07-20       Impact factor: 7.740

3.  Tissue processing and hematoxylin and eosin staining.

Authors:  Ada T Feldman; Delia Wolfe
Journal:  Methods Mol Biol       Date:  2014

4.  Automated segmentation of cell membranes to evaluate HER2 status in whole slide images using a modified deep learning network.

Authors:  Fariba Damband Khameneh; Salar Razavi; Mustafa Kamasak
Journal:  Comput Biol Med       Date:  2019-05-30       Impact factor: 4.589

5.  Assessment of algorithms for mitosis detection in breast cancer histopathology images.

Authors:  Mitko Veta; Paul J van Diest; Stefan M Willems; Haibo Wang; Anant Madabhushi; Angel Cruz-Roa; Fabio Gonzalez; Anders B L Larsen; Jacob S Vestergaard; Anders B Dahl; Dan C Cireşan; Jürgen Schmidhuber; Alessandro Giusti; Luca M Gambardella; F Boray Tek; Thomas Walter; Ching-Wei Wang; Satoshi Kondo; Bogdan J Matuszewski; Frederic Precioso; Violet Snell; Josef Kittler; Teofilo E de Campos; Adnan M Khan; Nasir M Rajpoot; Evdokia Arkoumani; Miangela M Lacle; Max A Viergever; Josien P W Pluim
Journal:  Med Image Anal       Date:  2014-11-29       Impact factor: 8.545

6.  A prospective study of surgical margin status in oral squamous cell carcinoma: a preliminary report.

Authors:  Ran Yahalom; Alex Dobriyan; Marilena Vered; Yoav P Talmi; Shlomo Teicher; Lev Bedrin
Journal:  J Surg Oncol       Date:  2008-12-15       Impact factor: 3.454

7.  Molecular subtype profiling of invasive breast cancers weakly positive for estrogen receptor.

Authors:  Brandon S Sheffield; Zuzana Kos; Karama Asleh-Aburaya; Xiu Qing Wang; Samuel Leung; Dongxia Gao; Jennifer Won; Christine Chow; Rakesh Rachamadugu; Inge Stijleman; Robert Wolber; C Blake Gilks; Nickolas Myles; Tom Thomson; Malcolm M Hayes; Philip S Bernard; Torsten O Nielsen; Stephen K L Chia
Journal:  Breast Cancer Res Treat       Date:  2016-02-04       Impact factor: 4.872

8.  An international Ki67 reproducibility study.

Authors:  Mei-Yin C Polley; Samuel C Y Leung; Lisa M McShane; Dongxia Gao; Judith C Hugh; Mauro G Mastropasqua; Giuseppe Viale; Lila A Zabaglo; Frédérique Penault-Llorca; John M S Bartlett; Allen M Gown; W Fraser Symmans; Tammy Piper; Erika Mehl; Rebecca A Enos; Daniel F Hayes; Mitch Dowsett; Torsten O Nielsen
Journal:  J Natl Cancer Inst       Date:  2013-11-07       Impact factor: 13.506

9.  High-throughput adaptive sampling for whole-slide histopathology image analysis (HASHI) via convolutional neural networks: Application to invasive breast cancer detection.

Authors:  Angel Cruz-Roa; Hannah Gilmore; Ajay Basavanhally; Michael Feldman; Shridar Ganesan; Natalie Shih; John Tomaszewski; Anant Madabhushi; Fabio González
Journal:  PLoS One       Date:  2018-05-24       Impact factor: 3.240

10.  Classification and mutation prediction from non-small cell lung cancer histopathology images using deep learning.

Authors:  Nicolas Coudray; Paolo Santiago Ocampo; Theodore Sakellaropoulos; Navneet Narula; Matija Snuderl; David Fenyö; Andre L Moreira; Narges Razavian; Aristotelis Tsirigos
Journal:  Nat Med       Date:  2018-09-17       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.